Literature DB >> 12023925

Fatal infection of a pet monkey with Human herpesvirus.

Hartwig P Huemer1, Clara Larcher, Thomas Czedik-Eysenberg, Norbert Nowotny, Martin Reifinger.   

Abstract

Concerns have been raised about pet monkeys as a potential threat to humans. We report the opposite situation, a danger to pets that arises from humans. Similar to herpesvirus B (Cercopithecine herpesvirus 1), which endangers humans but not its host species, Human herpesvirus 1 can act as a "killer virus" when crossing the species barrier to New World monkeys.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023925      PMCID: PMC2738492          DOI: 10.3201/eid0806.010341

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


A man was bitten by a marmoset (genus Callithrix) that had stomatitis. For exclusion of possible zoonotic pathogens, virus culture was performed on a specimen obtained from the marmoset’s oral mucosa. Virus isolation and typing with antibodies revealed Human herpesvirus 1 (HHV-1) infection, confirmed by type-specific polymerase chain reaction (PCR). Despite treatment, the monkey died 2 days after the sample was drawn. Standard veterinary practice is to consider whether diseases of primates that have been in close contact with humans might have been caused by human viruses. Acute stomatitis in pet monkeys can suggest HHV-1 infection, among other diseases, and systemic treatment with acyclovir may be appropriate.

Case Report

A 2-year-old male marmoset (Callithrix jacchus) was brought to a veterinary clinic with a 6-day history of severe necrotizing stomatitis, vomiting, and loss of appetite. The pet had been acquired by its owner 9 months earlier from an unknown source. Since then, it had usually been in close contact with its owner; she kept the pet on a leash and carried it directly on her body. A few days before being seen at the clinic, the animal had bitten a male visitor’s hand. Treatment of the marmoset included removal of the necrotic mucosal surface under anesthesia, local administration of acyclovir, and systemic application of antiemetic, antiphlogistic, and antibiotic agents. For diagnosis and exclusion of a possible zoonotic infection, a few samples of the altered oral mucosa were taken. Two days after veterinary intervention, the marmoset died. The owner refused a necropsy. Since communication with the owner ceased before diagnosis, questions about possible herpetic lesions on her or her guest who had been bitten by the monkey could not be answered. One specimen of the mucosal membrane was fixed in 10% buffered formalin, dehydrated in ethanol, cut into 4-μm sections, and stained with hematoxylin and eosin. Histologic examination showed severe necrotizing stomatitis with purulent inflammation and bacterial colonization of the debris. No epithelium remained nor any morphologically visible indication of a specific infection. Another specimen of the oral mucosa was homogenized in sterile phosphate-buffered saline, and the supernatant was used for cell culture and PCR analysis. Virus culture was performed on Vero cells originating from African green monkey kidney tissue (ATCC # CCL-81). One to two days later, a typical cytopathic effect was visible, consisting of plaques and cell rounding (Figure), which led to total detachment of the cells within 3 to 4 days.
Figure

Left: cytopathic effect in Vero cells consisting of a plaque and rounding of the cells after homogenized altered mucosal membrane of the marmoset was added to the cell culture. Right: type-specific polymerase chain reaction (PCR). Lanes 1 and 2 show fragments of 229-bp DNA amplified from Human herpesvirus 1 (HHV-1) and 241 bp from HHV-2 control strains, respectively. Lane S shows an HHV-1–specific PCR product amplified from an oral mucosa specimen of the marmoset; no product was obtained from supernatants of uninfected cell culture (lane -). Lane M, 1 kb DNA Ladder (GIBCO/BRL,Grand Island, NY).

Left: cytopathic effect in Vero cells consisting of a plaque and rounding of the cells after homogenized altered mucosal membrane of the marmoset was added to the cell culture. Right: type-specific polymerase chain reaction (PCR). Lanes 1 and 2 show fragments of 229-bp DNA amplified from Human herpesvirus 1 (HHV-1) and 241 bp from HHV-2 control strains, respectively. Lane S shows an HHV-1–specific PCR product amplified from an oral mucosa specimen of the marmoset; no product was obtained from supernatants of uninfected cell culture (lane -). Lane M, 1 kb DNA Ladder (GIBCO/BRL,Grand Island, NY). Cells were fixed with acetone/methanol, and immunofluorescence staining was carried out by using monoclonal and polyclonal antibodies against different species of Alphaherpesvirinae, including HHV-1 and -2, suid (SuHV-1), equid (EHV-1 to -4), bovine (BoHV-1), and nonhuman primate (CeHV-1) viruses. Positive staining was obtained with several monoclonal anti-HHV-1 antibodies directed against major glycoproteins (gC, gD, gE) as well as nonstructural proteins (infectious cell protein 0). Because reaction was also found to type-specific monoclonal antibodies such as HC1, HC2, and HC3 (, raised against gC of HHV-1, that virus was identified as the etiologic virus type. No cross-reactivity was observed with antisera against other species of herpesviruses, except a distinct reaction with a polyvalent anti-CeHV-1 antiserum due to the well-known cross-reactivity between HHV-1 and CeHV-1. To discriminate between HHV-1 and HHV-2, type-specific PCR was performed according to the protocol of Piiparinen and Vaheri, using their published primers (. Amplification products were detected in a 2% agarose gel stained with SYBR-Green. A 229-bp fragment was amplified, indicative of HHV-1 in the patient sample (lane S). Lanes 1 and 2 represent amplification products of HHV-1 strain Wal (229 bp) and HHV-2 strain D316 (241 bp), respectively (Figure). Additionally, a multiplex PCR reaction detecting HHV1-6 (including HHV-3, also called Varicella-zoster virus 1; HHV-4, commonly known as Epstein-Barr virus; and HHV-5, human cytomegalovirus) was performed by using the primer setup described by Tenorio et al. (. When these authors’ published set of primers was used, an HHV-1–specific fragment was also amplified (data not shown). Together with the reaction with different HHV-1–specific antibodies, including subtype-specific monoclonal antibodies, this was a clear indication of HHV-1 virus’s being the causative agent, excluding other possible primate herpesviruses.

Discussion

The increasing number of pet monkeys kept in households in the United States has prompted concerns about the potential for transmission of the primate herpesvirus (formerly SHBV, now termed nonhuman primate virus or CeHV-1). Unlike the situation in the natural host, CeHV-1 can cause fatal encephalitis in humans. Persons working with certain macaque species may be at particular risk (. In this report, we describe the reverse problem—the growing evidence that human herpesviruses endanger other primates (. Several nonhuman primate species have been reported to be susceptible to infection with human alphaherpesviruses. Experimental infections have been performed in owl monkeys, Cebus monkeys, Cotton-head Tamarins, and White-fronted Capuchins (–). Moreover, HHV-1 can naturally pass to primitive primates such as tree shrews (. In Old World primates, reports of human HHV-1 infections (–) indicate a virus-host relationship similar to that in humans, although sporadic fatal cases have been described, mainly in very young animals (,). In New World monkeys, however, HHV-1 seems to act more like a CeHV-1–type ”killer virus” (,). The case presented here is the third confirmed case of naturally transmitted HHV-1 infection in marmosets (–), and several other cases have been suspected to be of similar origin (,–). An outbreak of a fatal HHV-1 infection was observed recently in a group of common marmosets (C. jacchus) housed as a family group at the German Primate Center, Göttingen, Germany (K. Mätz-Rensing et al., unpub. data). All marmoset family members died within 3 days, indicating that HHV-1 has the capability to spread from monkey to monkey (K.D. Jentsch, pers. comm.). We were not able to determine an HHV-1 history for the people in our case’s immediate surroundings, but a negative history would not be informative because asymptomatic shedding often contributes to HHV-1 transmission. Because of the frequent but inapparent shedding of herpesviruses, direct contact of infected humans to animals should be limited. We suggest that keeping primates should be restricted to specialists, who are aware of the reciprocal hygienic risks. Use of gloves and eye protection, and even masks if aerosol transmission is suspected, is mandatory in standard biosafety precautions used in laboratory animal facilities. For more information, view the biosafety manual prepared by the Centers for Disease Control and Prevention and the National Institutes of Health at http://www.orcbs.msu.edu/biological/BMBL/BMBL-1.htm. Recommendations for precautions to be taken with any pet can be found at http://www.ahc.umn.edu/rar, http://www.cdc.gov/ncidod/op/pets.htm, and at http://www.cdc.gov/hiv/pubs/brochure/oi_pets.htm. In contrast, increasing numbers of websites praise a vast variety of exotic pets and only rarely mention the potential health hazards (especially to children) from close contact or keeping pet monkeys in the household. Careful animal handling and certain hygienic restrictions should be strongly recommended for the sake of both owners and pet monkeys.
  15 in total

1.  Latent Herpesvirus hominis from trigeminal and sacral dorsal root ganglia of Cebus monkeys.

Authors:  W C Reeves; R F DiGiacomo; E R Alexander; C K Lee
Journal:  Proc Soc Exp Biol Med       Date:  1976-11

2.  Microbial flora of imported marmosets: viruses and enteric bacteria.

Authors:  B L Murphy; J E Maynard; D H Krushak; K R Berquist
Journal:  Lab Anim Sci       Date:  1972-06

3.  The gibbon (Hylobates lar); a new primate host for Herpesvirus hominia. I. A natural epizootic in a laboratory colony.

Authors:  P C Smith; T M Yuill; R D Buchanan; J S Stanton; V Chaicumpa
Journal:  J Infect Dis       Date:  1969-09       Impact factor: 5.226

4.  Detection and typing of human herpesviruses by multiplex polymerase chain reaction.

Authors:  A Tenorio; J E Echevarría; I Casas; J M Echevarría; E Tabarés
Journal:  J Virol Methods       Date:  1993-10       Impact factor: 2.014

5.  Fatal Herpesvirus hominis encephalitis in a white-handed gibbon.

Authors:  E Ramsay; E L Stair; A E Castro; M I Marks
Journal:  J Am Vet Med Assoc       Date:  1982-12-01       Impact factor: 1.936

6.  Spontaneous herpes simplex virus infection in common marmosets (Callithrix jacchus).

Authors:  C Juan-Sallés; J A Ramos-Vara; N Prats; J Solé-Nicolás; J Segalés; A J Marco
Journal:  J Vet Diagn Invest       Date:  1997-07       Impact factor: 1.279

7.  Natural Herpesvirus hominis infection of tree shrews (Tupaia glis).

Authors:  H M McClure; M E Keeling; B Olberding; R D Hunt; L V Melendez
Journal:  Lab Anim Sci       Date:  1972-08

8.  Natural genital herpesvirus hominis infection in chimpanzees (Pan troglodytes and Pan paniscus).

Authors:  H M McClure; R B Swenson; S S Kalter; T L Lester
Journal:  Lab Anim Sci       Date:  1980-10

9.  Spontaneous generalized Herpesvirus hominis infection of a lowland gorilla (Gorilla gorilla gorilla).

Authors:  A Heldstab; D Rüedi; W Sonnabend; F Deinhardt
Journal:  J Med Primatol       Date:  1981       Impact factor: 0.667

10.  B-virus from pet macaque monkeys: an emerging threat in the United States?

Authors:  S R Ostrowski; M J Leslie; T Parrott; S Abelt; P E Piercy
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

View more
  12 in total

Review 1.  The development of small primate models for aging research.

Authors:  Kathleen E Fischer; Steven N Austad
Journal:  ILAR J       Date:  2011

2.  Herpes B virus utilizes human nectin-1 but not HVEM or PILRα for cell-cell fusion and virus entry.

Authors:  Qing Fan; Melanie Amen; Mallory Harden; Alberto Severini; Anthony Griffiths; Richard Longnecker
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

3.  A model of genital herpes simplex virus Type 1 infection in Rhesus Macaques.

Authors:  Meropi Aravantinou; Ines Frank; Geraldine Arrode-Bruses; Moriah Szpara; Brooke Grasperge; James Blanchard; Agegnehu Gettie; Nina Derby; Elena Martinelli
Journal:  J Med Primatol       Date:  2017-08       Impact factor: 0.667

4.  Specific detection and identification of herpes B virus by a PCR-microplate hybridization assay.

Authors:  Chika Oya; Yoshitsugu Ochiai; Yojiro Taniuchi; Takashi Takano; Fukiko Ueda; Yasuhiro Yoshikawa; Ryo Hondo
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

Review 5.  Monkey B virus (Cercopithecine herpesvirus 1).

Authors:  David Elmore; Richard Eberle
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982

6.  Human herpesvirus 1 in wild marmosets, Brazil, 2008.

Authors:  Camila S Longa; Savio F Bruno; Amaury R Pires; Phyllis C Romijn; Leda S Kimura; Carols H C Costa
Journal:  Emerg Infect Dis       Date:  2011-07       Impact factor: 6.883

7.  Tales from the crypt and coral reef: the successes and challenges of identifying new herpesviruses using metagenomics.

Authors:  Charlotte J Houldcroft; Judith Breuer
Journal:  Front Microbiol       Date:  2015-03-13       Impact factor: 5.640

8.  Herpes simplex virus type 1 infection in two pet marmosets in Japan.

Authors:  Kei Imura; James Kenn Chambers; Kazuyuki Uchida; Shunsuke Nomura; Satoshi Suzuki; Hiroyuki Nakayama; Yasutsugu Miwa
Journal:  J Vet Med Sci       Date:  2014-09-11       Impact factor: 1.267

9.  Herpes B virus gD interaction with its human receptor--an in silico analysis approach.

Authors:  Lingke Li; Zhengliang Qiu; Yan Li; Feng Liang; Huahu Ye; Yongqin Cai; Wanfeng Guo; Yan Li; Junjie Yue
Journal:  Theor Biol Med Model       Date:  2014-06-06       Impact factor: 2.432

10.  Understanding Primate Herpesviruses.

Authors:  R Eberle; L Jones-Engel
Journal:  J Emerg Dis Virol       Date:  2017-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.